| scholarly article | Q13442814 |
| P2093 | author name string | R C LeBoeuf | |
| D L Wilson | |||
| V V Kunjathoor | |||
| P2860 | cites work | THE EFFECT OF ALLOXAN DIABETES ON EXPERIMENTAL ATHEROSCLEROSIS IN THE RAT | Q76850142 |
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures | Q26778382 | ||
| Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes | Q34201185 | ||
| Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice | Q35610718 | ||
| Lipoprotein glycation and its metabolic consequences | Q35840925 | ||
| George Lyman Duff Memorial Lecture. Atherogenesis in diabetes | Q36136751 | ||
| Quantitative assessment of atherosclerotic lesions in mice | Q36456167 | ||
| Role of oxidative stress in development of complications in diabetes | Q37681089 | ||
| Diabetes and atherosclerosis: an epidemiologic view | Q39764302 | ||
| Diabetic microvascular complications and growth factors. | Q40451379 | ||
| Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy. | Q40920727 | ||
| Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis | Q42025348 | ||
| Synthetic low and high fat diets for the study of atherosclerosis in the mouse | Q43607933 | ||
| Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. | Q44059065 | ||
| Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus | Q44553205 | ||
| Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification | Q45200610 | ||
| Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study | Q50584833 | ||
| Regulation by nutritional status of lipids and apolipoproteins A-I, A-II, and A-IV in inbred mice. | Q51597405 | ||
| A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. | Q51655087 | ||
| Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis. | Q54337059 | ||
| Pathology of atherosclerosis in cholesterol-fed, susceptible mice | Q67800087 | ||
| Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall | Q68446303 | ||
| Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles | Q70164761 | ||
| Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts | Q70598590 | ||
| Atherosclerosis and myocardial ischemic lesions in alloxan-diabetic rabbits fed a low cholesterol diet | Q70701833 | ||
| Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000 | Q71508550 | ||
| Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics | Q71638929 | ||
| Can insulin promote atherogenesis by altering cellular cholesterol metabolism? | Q72037515 | ||
| Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia | Q72150727 | ||
| Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow | Q72406593 | ||
| A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association | Q72415283 | ||
| ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree | Q72689998 | ||
| Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues | Q72761827 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1767-1773 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Increased atherosclerosis in streptozotocin-induced diabetic mice | |
| P478 | volume | 97 |
| Q37666671 | 2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis |
| Q51277451 | A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans. |
| Q37364649 | Absence of P-selectin delays fatty streak formation in mice |
| Q78004667 | Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol |
| Q74445952 | Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients |
| Q35415550 | Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process. |
| Q41763265 | Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus. |
| Q26822630 | Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches |
| Q36970065 | Atherosclerosis and cardiac function assessment in low-density lipoprotein receptor-deficient mice undergoing body weight cycling |
| Q40730332 | Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice |
| Q51570758 | C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. |
| Q45937038 | Cardiovascular risk continuum: implications of insulin resistance and diabetes. |
| Q43678508 | Cardiovascular structure and function in baboons with Type 1 diabetes -- a transvenous ultrasound study |
| Q36687957 | Cellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium |
| Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
| Q34946924 | Connective tissue growth factor (CTGF) expression modulates response to high glucose |
| Q37202057 | Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice |
| Q41457652 | Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications. |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q33649275 | Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. |
| Q53486855 | Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. |
| Q36976985 | Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents |
| Q54489626 | Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients. |
| Q49703070 | Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes |
| Q34559840 | Genetic determinants of atherosclerosis, obesity, and energy balance in consomic mice |
| Q34080318 | Genetic modifiers of atherosclerosis in mice |
| Q36209386 | Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways |
| Q46141799 | Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability |
| Q35009647 | In vivo bioluminescence imaging of inducible nitric oxide synthase gene expression in vascular inflammation |
| Q34459819 | Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury |
| Q55242448 | Increasing Atherosclerosis in Streptozotocin-Induced Diabetes into Four Groups of Mice. |
| Q27011696 | Insulin resistance, hyperglycemia, and atherosclerosis |
| Q77994097 | Interleukin-1beta-induced nitric oxide production in rat aortic endothelial cells: inhibition by estradiol in normal and high glucose cultures |
| Q28367084 | Iron overload diminishes atherosclerosis in apoE-deficient mice |
| Q28198287 | Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis |
| Q26766350 | Large animal models of cardiovascular disease |
| Q44517931 | Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy |
| Q54036769 | Long-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries. |
| Q37151524 | Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice |
| Q43865549 | Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice |
| Q33905765 | Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice |
| Q38293028 | Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice |
| Q58829265 | Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia |
| Q46418378 | Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes |
| Q28070313 | Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models |
| Q43687605 | Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis |
| Q43996678 | Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice |
| Q37606460 | PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress |
| Q40289404 | Quantitative analysis and characterization of atherosclerotic lesions in the murine aortic sinus |
| Q44807760 | Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways |
| Q50925617 | Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. |
| Q53558779 | Regulation of vascular proteoglycan synthesis by metabolic factors associated with diabetes. |
| Q98613686 | Regulatory Effects of O-GlcNAcylation in Vascular Smooth Muscle Cells on Diabetic Vasculopathy |
| Q44547302 | Response to sex hormones differs in atherosclerosis-susceptible and -resistant mice. |
| Q36416215 | Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? |
| Q34153709 | Role of diabetes, hypertension, and cigarette smoking on atherosclerosis |
| Q45259197 | Role of lipids in the early developmental stages of experimental immune diabetes induced by multiple low-dose streptozotocin |
| Q52666460 | SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice. |
| Q51370181 | Salutary effect of Cassia auriculata L. Leaves on hyperglycemia-induced atherosclerotic environment in streptozotocin rats. |
| Q42906142 | Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully ‘switchable’ in vivo mouse model of diabetes |
| Q53359503 | Streptozotocin-Induced Diabetic Models in Mice and Rats. |
| Q42721766 | Streptozotocin-induced diabetic models in mice and rats |
| Q41009444 | Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts |
| Q58742042 | The Flavonoid Kaempferol Ameliorates Streptozotocin-Induced Diabetes by Suppressing Hepatic Glucose Production |
| Q43600015 | The lipid-lowering effect of trans-dehydrocrotonin, a clerodane diterpene from Croton cajucara Benth. in mice fed on high-fat diet |
| Q35667361 | Unbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathy |
| Q35881759 | Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture |
| Q80968903 | Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis |
| Q30485641 | Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis |
| Q39951404 | Why does diabetes increase atherosclerosis? I don't know! |
Search more.